|
⚲
|
| Keyboard |
| Chakma Justin
✚
|
|
|---|---|
| CIK # | 0001951238 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001951238] | |
| 4 | [0001951238] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Chakma Justin | |
| ARS Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ARS Pharmaceuticals Inc SPRY
Stock option (right to buy) · derivative
|
2026-01-02 | Grant | 240,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2025-11-12 | Option exercise | 30,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2025-11-12 | Option exercise | 30,000 | $0.84 | 25,200 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2025-11-12 | Sell | 30,000 | $8.91 | 267,300 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2025-11-12 | Sell | 136,380 | $8.86 | 1,208,327 |
|
ARS Pharmaceuticals Inc SPRY
Stock option (right to buy) · derivative
|
2025-01-02 | Grant | 274,100 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-13 | Option exercise | 27,272 | $1.44 | 39,272 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-12-13 | Option exercise | 27,272 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-13 | Sell | 27,272 | $12.06 | 328,900 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-12 | Sell | 117,333 | $12.27 | 1,439,676 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-12 | Option exercise | 117,333 | $0.84 | 98,560 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-12-12 | Option exercise | 117,333 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-10 | Sell | 50,000 | $13.15 | 657,500 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-12-10 | Option exercise | 50,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-10 | Option exercise | 50,000 | $0.84 | 42,000 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-06 | Sell | 50,000 | $14.23 | 711,500 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-12-06 | Option exercise | 50,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-06 | Option exercise | 50,000 | $0.84 | 42,000 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-05 | Option exercise | 49,640 | $0.84 | 41,698 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-05 | Sell | 49,640 | $14.13 | 701,413 |
| showing 20 of 42 most recent transactions | |||||